{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Orlando",
      "address_1": "6700 Conroy Windermere Rd",
      "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes",
      "address_2": "Suite 140",
      "product_quantity": "3",
      "code_info": "B5019 Exp 10/31/13, B3525 Exp 8/25/13 and B3122 Exp 8/22/13",
      "center_classification_date": "20130711",
      "distribution_pattern": "Nationwide and PR",
      "state": "FL",
      "product_description": "Oxytocin 20 units/ml Injection, compounded by Olympia Pharmacy, Orlando, FL",
      "report_date": "20130717",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy",
      "recall_number": "D-764-2013",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "product_type": "Drugs",
      "event_id": "65360",
      "recall_initiation_date": "20130529",
      "postal_code": "32835-3500",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Ongoing"
    }
  ]
}